Uscom

Uscom EBIT CAGR 5Y

The EBIT CAGR (5 Year) of Uscom (UCM.AX) as of Oct 18, 2026 is 15.71 %. In the previous year, EBIT CAGR (5 Year) was 15.71 % — a change of 0.00% (lower).

EBIT CAGR 5Y

15.71 %

YoY

0.00%

Last updated:

EBIT CAGR (5 Year) of Uscom is 2025 15.71 % . EBIT CAGR (5 Year) of Uscom was 2024 15.71 % . It decreases by 0.00% lower compared to the previous year.

The Uscom EBIT CAGR 5Y history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT CAGR 5Y
Date
EBIT CAGR 5Y
Jan 1, 2018
15.71 AUD
Jan 1, 2019
15.71 AUD
Jan 1, 2020
15.71 AUD
Jan 1, 2021
15.71 AUD
Jan 1, 2022
15.71 AUD
Jan 1, 2023
15.71 AUD
Jan 1, 2024
15.71 AUD
Jan 1, 2025
15.71 AUD
The Uscom EBIT CAGR 5Y history
YEAREBIT CAGR 5YYoY
15.71 %0.00%
15.71 %0.00%
15.71 %0.00%
15.71 %0.00%
15.71 %0.00%
15.71 %0.00%
15.71 %0.00%
15.71 %0.00%
15.71 %0.00%
15.71 %0.00%
15.71 %0.00%
15.71 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Uscom Stock analysis

What does Uscom do? Uscom Ltd is an Australian company that was founded in 2000. The company focuses on the development, manufacturing, and marketing of medical equipment and devices, with a focus on cardiovascular diagnostics. The company is headquartered in Sydney, Australia, and has branches in Europe, North America, and Asia. Uscom consists of a team of experienced scientists, engineers, and medical professionals who collaborate to manufacture and offer high-quality products that are recognized in the medical field worldwide. Uscom's business model is to develop innovative devices that help doctors and medical professionals diagnose and treat their patients more effectively. Over the years, the company has diversified its portfolio and now offers a variety of products that can be classified into different categories. One of Uscom's main divisions is the manufacturing of ultrasound devices that can be used to measure blood flow, blood pressure, and other important cardiovascular parameters. These devices are particularly useful in the diagnosis and monitoring of patients with cardiovascular diseases such as hypertension, heart failure, and stroke. Uscom also offers a range of devices specifically designed for use in intensive care units and emergency rooms. These devices include non-invasive blood pressure monitors, ventilators, and monitoring systems that enable quick and accurate patient monitoring. These devices are used by medical professionals worldwide to save lives and improve the treatment of critical illnesses. In addition to medical devices, Uscom also provides a variety of training and continuing education programs for medical professionals. These trainings include courses on device usage as well as general trainings on cardiovascular health and diagnosis. In recent years, Uscom has specialized in the development and marketing of telemedicine solutions. These solutions allow doctors and patients to communicate and exchange information remotely. This is particularly useful in providing care to patients in remote areas and in other situations where access to medical professionals is limited. One of Uscom's latest developments is a portable ultrasound Doppler device that can be used to measure blood flow, stroke volume, and other important cardiovascular parameters. This device is lightweight and easy to use, enabling doctors to diagnose patients quickly and accurately in any clinical setting. Overall, Uscom has established a good reputation in the medical industry and is considered a leading company in cardiovascular diagnostics. The company continues its efforts to develop innovative products and solutions that can improve the lives of patients worldwide. Uscom is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Uscom stock

EBIT CAGR (5 Year) of Uscom is 15.71 % in 2025.

On Eulerpool you can find the complete historical development of EBIT CAGR (5 Year) Uscom since 2006 – with annual values, charts, and detailed analysis.

The 5-year EBIT CAGR shows the compound annual growth rate of EBIT over the past five years.

To evaluate EBIT CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (5 Year).

EBIT CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (5 Year)'s Uscom historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Uscom

All Key Metrics — Uscom